1. The Risk of Immunosuppression: A Case of Salmonella Meningitis
- Author
-
Tamar Geva, Kenneth M. Wener, David P. Lerner, and Joshua Dower
- Subjects
030203 arthritis & rheumatology ,medicine.medical_specialty ,Salmonella species ,business.industry ,medicine.medical_treatment ,Leg pain ,Case Report ,Immunosuppression ,General Medicine ,medicine.disease ,lcsh:Infectious and parasitic diseases ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Rheumatoid arthritis ,medicine ,Ceftriaxone ,Bacterial meningitis ,lcsh:RC109-216 ,030212 general & internal medicine ,Presentation (obstetrics) ,Salmonella meningitis ,business ,medicine.drug - Abstract
Salmonella meningitis is a rare infection, particularly in adults. We report the case of a 75-year-old female with a history of rheumatoid arthritis on TNF-antagonist immunosuppressive therapy who initially presented to the hospital for management of back and leg pain and was ultimately diagnosed with bacterial meningitis secondary to Salmonella species infection. She was treated with ceftriaxone with slow improvement in neurological function. Though the source of infection was never clearly identified from multiple imaging studies, we suspect the severity of her presentation was due to her history of TNF-antagonist use.
- Published
- 2018